InsidersTradesSigma
Track the 莎普爱思 stock price and the full management transaction log of the company, a listed issuer based in China. Shares are quoted on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 莎普爱思 has recorded 11 insider filings. Market capitalisation: €1.9bn. The latest transaction was disclosed on 28 November 2022 (Sale). Among the most active insiders: 胡正国. The full history is free.
11
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€2m
11 ops.
Sell Volume
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,378 of 29,057 companies
24.7
score / 100
Value22
Quality27
FCF yld-2.5%
Earn yld-12%
EV/EBITDA·
ROE-19%
Gross mgn46%
Net mgn-52%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 28 November 2022
Declarations11 total
11 of 11 declarations
About 莎普爱思
莎普爱思 is a company operating in the health and pharmaceutical sector, listed on the XSHG market. It focuses on the development and marketing of innovative pharmaceutical products.